<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Exp Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Exp Immunol</journal-id><journal-id journal-id-type="publisher-id">cei</journal-id><journal-title-group><journal-title>Clinical and Experimental Immunology</journal-title></journal-title-group><issn pub-type="ppub">0009-9104</issn><issn pub-type="epub">1365-2249</issn><publisher><publisher-name>Blackwell Science Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17286802</article-id><article-id pub-id-type="pmc">PMC1868885</article-id><article-id pub-id-type="doi">10.1111/j.1365-2249.2007.03330.x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Translational Studies</subject><subj-group><subject>Infection</subject></subj-group></subj-group></article-categories><title-group><article-title>Bronchoalveolar neutrophils, interferon gamma-inducible protein 10
and interleukin-7 in AIDS-associated tuberculosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kibiki</surname><given-names>G S</given-names></name><xref rid="au1" ref-type="aff">*</xref></contrib><contrib contrib-type="author"><name><surname>Myers</surname><given-names>L C</given-names></name><xref rid="au2" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Kalambo</surname><given-names>C F</given-names></name><xref rid="au1" ref-type="aff">*</xref></contrib><contrib contrib-type="author"><name><surname>Hoang</surname><given-names>S B</given-names></name><xref rid="au3" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Stoler</surname><given-names>M H</given-names></name><xref rid="au2" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Stroup</surname><given-names>S E</given-names></name><xref rid="au4" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author"><name><surname>Houpt</surname><given-names>E R</given-names></name><xref rid="au4" ref-type="aff">&#x000a7;</xref></contrib><aff id="au1"><label>*</label><institution>Medical Department and Radiology
Department, Kilimanjaro Christian Medical Centre</institution>
<addr-line>Moshi, Tanzania</addr-line></aff><aff id="au2"><label>&#x02020;</label><institution>Department of Pathology,
University of Virginia</institution>
<addr-line>Charlottesville, VA, USA</addr-line></aff><aff id="au3"><label>&#x02021;</label><institution>Digestive Health Center of
Excellence, University of Virginia</institution>
<addr-line>Charlottesville, VA, USA</addr-line></aff><aff id="au4"><label>&#x000a7;</label><institution>Division of Infectious Diseases
and International Health, University of Virginia</institution>
<addr-line>Charlottesville, VA, USA</addr-line></aff></contrib-group><author-notes><corresp id="cor1">Correspondence: Eric R. Houpt, Division of Infectious Diseases
and International Health, MR4 Building, Room 2144, Charlottesville, VA
22908-1363, USA. E-mail: <email>erh6k@virginia.edu</email></corresp><fn><p>Re-use of this article is permitted in accordance with the Creative Commons
Deed, Attribution 2.5, which does not permit commercial exploitation.</p></fn></author-notes><pub-date pub-type="ppub"><month>5</month><year>2007</year></pub-date><pub-date pub-type="pmc-release"><month>5</month><year>2007</year></pub-date><volume>148</volume><issue>2</issue><fpage>254</fpage><lpage>259</lpage><history><date date-type="accepted"><day>02</day><month>1</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9; 2007 The Author(s); Journal compilation &#x000a9; 2007
British Society for Immunology</copyright-statement><copyright-year>2007</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/2.5/</ali:license_ref><license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution
2.5, which does not permit commercial exploitation.</license-p></license></permissions><abstract><p>During advanced AIDS tuberculosis (TB) often presents atypically with
smear-negative and non-cavitary disease, yet immune features associated with
this change are poorly characterized. We examined the local immune response in a
cohort of Tanzanian AIDS-associated TB patients who underwent bronchoalveolar
lavage. TB infection was confirmed in bronchoalveolar lavage (BAL) fluid by
culture, probe and polymerase chain reaction (PCR). Among TB patients CD4 count
correlated positively with the extent of cavitary disease as well as BAL TB load
(qPCR C<sub>T</sub>). TB patients had significantly higher
granulocyte&#x02013;macrophage colony-stimulating factor (GM-CSF) than non-TB
patients, and those with non-cavitary TB had significantly higher BAL interferon
gamma-inducible protein (IP-10) and interleukin (IL)-7 than those with cavities.
BAL neutrophils were as prevalent as monocytes/macrophages or epithelial
cells, and immunohistochemistry revealed that neutrophils,
monocytes/macrophages, and epithelial cells were major sources of the
IP-10 and IL-7. These data suggest a dysregulated cytokine profile may
contribute to the TB of advanced AIDS.</p></abstract><kwd-group><kwd>cavity</kwd><kwd>GM-CSF</kwd><kwd>IL-7</kwd><kwd>IP-10</kwd><kwd>neutrophils</kwd><kwd>tuberculosis</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p><italic>Mycobacterium tuberculosis</italic> is the world's most deadly
bacterial pathogen [<xref rid="b1" ref-type="bibr">1</xref>].
Tuberculosis (TB) rates and mortality are higher in HIV infected individuals
[<xref rid="b2" ref-type="bibr">2</xref>] and TB accelerates HIV
replication and heterogeneity [<xref rid="b3" ref-type="bibr">3</xref>,<xref rid="b4" ref-type="bibr">4</xref>]. The tendency for TB to present
atypically during AIDS, without the hallmark of upper lobe cavitary lung disease, is
well established [<xref rid="b5" ref-type="bibr">5</xref>&#x02013;<xref rid="b8" ref-type="bibr">8</xref>]. A proposed explanation for the lack
of lung cavitation with advanced AIDS is the loss of a CD4-mediated interferon
(IFN)-&#x003b3; or delayed-type hypersensitivity (DTH) response to drive the
granuloma and cavitation process [<xref rid="b9" ref-type="bibr">9</xref>,<xref rid="b10" ref-type="bibr">10</xref>]. Unfortunately,
supporting data that evaluate the cytokine profile from AIDS-associated TB patients
are few, particularly from the bronchoalveolar compartment, and particularly from
sub-Saharan Africa where the disease burden is highest. We therefore sought to
examine the immune characteristics of AIDS patients with well-documented TB
infection across a range of CD4 counts and radiographic presentations.</p></sec><sec><title>Materials and methods</title><sec><title>Patient population and bronchoscopy</title><p>Informed consent was obtained from all participants and the University of
Virginia (UVA) Human Investigation Committee and the Kilimanjaro Christian
Medical Centre (KCMC) Ethics Committee reviewed and approved the project.
Bronchoscopy with bronchoalveolar lavage was performed by standard procedure
using a flexible fibreoptic bronchoscope (Olympus p45, Tokyo, Japan) wedged into
involved segmental bronchi. In the case of diffuse lung involvement, the scope
was wedged into one of the segmental bronchi of the right middle lobe.</p></sec><sec><title>Detection of TB</title><p>Each bronchoalveolar lavage (BAL) fluid was assayed by acid-fast bacilli (AFB)
smear (at KCMC), culture (2 ml on solid and liquid media at UVA), polymerase
chain reaction (PCR) (at UVA, see below) and by Ziehl&#x02013;Neelsen stain of
BAL cell block (at UVA, see below). TB infection was defined by positive culture
with confirmation of <italic>M. tuberculosis</italic> complex by DNA probe
(<italic>n</italic> = 13). The TB-negative group (<italic>n</italic>
= 21) was defined as AFB smear, culture and PCR negativity. Eight
patients were excluded from further analysis because their TB status was
uncertain (five were smear-positive but culture-negative and PCR-negative; three
were smear-negative and culture-negative but PCR-positive). Four patients were
excluded because their BAL grew non-tuberculous mycobacteria and we could not
rule out overgrowth of TB. Among the non-TB cases, 10 had the bronchoscopic
appearance of Kaposi's sarcoma. Other diagnostic tests were performed as
per the attending physician's orders but were not revealing.</p></sec><sec><title>TB PCR</title><p>PCR for the IS6110 gene was performed on BAL fluid using the assay and primers of
Pounder <italic>et al</italic>. [<xref rid="b11" ref-type="bibr">11</xref>]. Briefly, 2 ml of the BAL fluid was centrifuged at 16 000
<bold><italic>g</italic></bold> for 5 min and 200 &#x000b5;l of PrepMan
Ultra sample preparation reagent (Applied Biosystems, Foster City, CA, USA) was
added to the pellet. The mixture was vortexed, boiled for 15 min and centrifuged
at 16 000 <bold><italic>g</italic></bold> for 5 min to remove cellular debris.
PCR of 5 &#x000b5;l of extracted DNA was performed in a total volume of 25
&#x000b5;l containing 12&#x000b7;5 &#x000b5;l of iQ SYBR Green Supermix 2&#x000d7;
(Bio-Rad, Hercules, CA, USA), i<italic>Taq</italic> DNA polymerase (50
U/ml), 6 mM MgCl<sub>2</sub>, 20 nM SYBR Green I, 0&#x000b7;5 &#x000b5;M of
each primer, 100 ng <italic>M. tuberculosis</italic> DNA for positive control
and water for negative control. Cycling conditions entailed 1 cycle at
95&#x000b0;C for 15 min followed by 40 cycles at 95&#x000b0;C for 10 s,
58&#x000b0;C for 20 s and 76&#x000b0;C for 20 s.</p></sec><sec><title>Radiographic analysis</title><p>All patients had chest radiographs (CXR) read in blinded fashion by a radiologist
(C. F. K.). CXR scores were determined as described previously [<xref rid="b12" ref-type="bibr">12</xref>]. The extent of cavitation was
estimated by measuring the diameter of each cavity (mm) on CXR, assuming
cavities were roughly spherical (4/3 &#x003c0; r<sup>3</sup>), and summing
the volumes of all cavities.</p></sec><sec><title>CD4 count</title><p>CD4 count was measured using the Coulter Manual CD4 Count kit (Beckman Coulter,
Hialeah, FL, USA).</p></sec><sec><title>Cytokine measurements</title><p>Five ml of BAL fluid was added to dithiothreitol (DTT) (0&#x000b7;05% final
concentration) to dissolve mucus and filtered with 0&#x000b7;22 &#x000b5;m filters
(Millex GP, Millipore, Cork, Ireland). Fluid was then concentrated in Amicon
Ultra-15 filters (10 000 MWCO; Millipore) and assayed for 22
cytokines/chemokines using the human 22-plex cytokine kit (Upstate,
Charlottesville, VA, USA) on a Luminex-100 instrument, according to the
manufacturer's instructions. For transforming growth factor
(TGF)-&#x003b2;1 quantification, samples were acid-activated to pH 1&#x000b7;5
with 1 N HCl for 60 min prior to assay. To adjust for BAL dilution, all cytokine
data were normalized to the total protein content in the fluid as determined by
bicinchoninic acid (BCA) assay (Pierce, Rockford, IL, USA).</p></sec><sec><title>Histology and immunohistochemistry (IHC)</title><p>Ten ml of BAL fluid was stored in RNALater (Ambion, Austin, TX, USA) at
&#x02212;70&#x000b0;C and cell blocks were made by pelleting the material, fixing
in 10% formalin and embedding in paraffin. Tissue sections were stained
with haematoxylin and eosin, Ziehl&#x02013;Neelsen and IHC was performed for
inducible protein (IP)-10 and interleukin (IL)-7. All pathology was scored
blindly by a pathologist (L. M.). For each sample a cellularity score was
determined for epithelial cells, monocytes/macrophages, lymphocytes and
neutrophils as follows: 0 = none, 1 = few, 2 = scattered, 3
= many. Ziehl&#x02013;Neelsen-stained cell blocks were viewed at
1000&#x000d7; and scored for AFB positivity as follows: 0 = none, 1
= rare, 2 = few, 3 = scattered throughout. For IHC,
3-&#x003bc;-thick paraffin sections were obtained using a Leica Microtome,
mounted on superfrost/PLUS glass slides and deparaffinized to deionized
water. Samples were incubated overnight at 4&#x000b0;C using IP-10 and IL-7
antibodies (R&#x00026;D systems, Minneapolis, MN, USA), with dilutions ranging
from 5 &#x000b5;g/ml to 125 &#x000b5;g/ml. Samples were rinsed in
phosphate-buffered saline (PBS) and incubated with a biotinylated secondary
antibody for 30 min at room temperature. Samples were then incubated with the
ABC kit (Vector, Burlingame, CA, USA) for 30 min at room temperature, rinsed in
PBS and stained with 3,3&#x02032; diaminobenzidine.</p><p>(DAB) substrate (Vector) before counterstaining. An IHC score was determined for
each cell population (epithelial cells, monocytes/macrophages,
lymphocytes and neutrophils) according to the following scale: 0 = weak,
majority of cells not staining; 1 = intermediate; 2 = strong,
majority of cells staining.</p></sec><sec><title>Statistics</title><p>Means and medians were compared using <italic>t</italic>-test and
Mann&#x02013;Whitney test, respectively. Correlations were measured using the
Pearson linear correlation. All <italic>P</italic>-values are two-tailed. Data
shown are mean &#x000b1; standard deviation (s.d.) unless indicated
otherwise.</p></sec></sec><sec><title>Results</title><sec><title>Utility of BAL PCR for detection of TB infection</title><p>The endoscopy unit at the KCMC is one of few centres in the region equipped for
bronchoscopy and serves as a referral centre for patients with chest disease of
unknown aetiology. We enrolled and obtained consent from 46 such patients known
to be HIV-positive and performed TB diagnostics and cytokine analysis on BAL. TB
infection was identified in 13/46 (28%) by culture with
confirmation of <italic>M. tuberculosis</italic> complex by DNA probe. Against
this gold standard, BAL PCR exhibited better sensitivity and specificity than
BAL AFB smear (100%/91% <italic>versus</italic>
54%/85%). Furthermore, real-time PCR C<sub>T</sub> (cycle
threshold) exhibited the expected quantitative correlation with time to positive
culture (C<sub>T</sub>
<italic>versus</italic> days to positivity; <italic>r</italic> =
0&#x000b7;68, <italic>P</italic> = 0&#x000b7;01) and AFB score
(C<sub>T</sub>
<italic>versus</italic> AFB score; <italic>r</italic> = 0&#x000b7;67,
<italic>P</italic> = 0&#x000b7;02).</p></sec><sec><title>CD4 count correlates with cavitary disease and endobronchial TB
burden</title><p>There were no significant differences between the TB-positive and TB-negative
populations in terms of age, gender, CXR score [4&#x000b7;8 &#x000b1;
1&#x000b7;4 <italic>versus</italic> 7&#x000b7;4 &#x000b1; 0&#x000b7;9,
<italic>P</italic> = not significant (n.s.)] or CD4 count (194
&#x000b1; 41 <italic>versus</italic> 146 &#x000b1; 31, <italic>P</italic> =
n.s.). Among TB patients, average CD4 count was higher in patients with cavities
as detected by CXR (<xref rid="fig01" ref-type="fig">Fig. 1a</xref>).
Additionally, CD4 count correlated positively with cavitary volume and BAL Tb
burden (qPCR C<sub>T</sub>; <xref rid="fig01" ref-type="fig">Fig.
1b,c</xref>).</p><fig position="float" id="fig01"><label>Fig. 1</label><caption><p>Association between CD4 count, cavitary disease, and tuberculosis (TB)
polymerase chain reaction (PCR) in bronchoalveolar lavage (BAL). CD4
count of HIV<sup>+</sup>/TB<sup>+</sup> patients
was compared (a) between those with and without cavitary findings on
chest radiographs (CXR), (b) <italic>versus</italic> total cavitary
volume and (c) <italic>versus</italic> BAL PCR cycle threshold
(C<sub>T</sub>). (a) Mean &#x000b1; s.e.; *<italic>P</italic>
&#x0003c; 0&#x000b7;05 by <italic>t</italic>-test or Mann&#x02013;Whitney
test. Correlations used the Pearson linear correlation.</p></caption><graphic xlink:href="cei0148-0254-f1" position="float"/></fig></sec><sec><title>BAL cytokine/chemokine response in AIDS-associated TB</title><p>Scant data are available on the BAL response during AIDS-associated TB. Most
reports derive from HIV-negative TB in developed countries and findings have
been extremely variable [<xref rid="b13" ref-type="bibr">13</xref>&#x02013;<xref rid="b15" ref-type="bibr">15</xref>]. First,
we examined the cell blocks prepared from the BAL fluid. As expected,
lymphocytes were scant (cellularity score 0&#x000b7;6 &#x000b1; 0&#x000b7;5), but
we were surprised to find a substantial amount of neutrophils, many of which
contained intracellular <italic>M. tuberculosis</italic> bacilli (<xref rid="fig02" ref-type="fig">Fig. 2</xref>; cellularity scores 2&#x000b7;1
&#x000b1; 0&#x000b7;9 for neutrophils, 2&#x000b7;3 &#x000b1; 0&#x000b7;7 for
monocytes/macrophages and 2&#x000b7;0 &#x000b1; 0&#x000b7;6 for epithelial
cells, respectively, <italic>P</italic> = n.s.). We next performed a
broad characterization of 23 chemokines and cytokines in BAL fluid using the
Luminex assay, with all cytokine data normalized for dilution against the total
protein content in the fluid. The analysis showed that the TB-positive group
exhibited higher BAL granulocyte&#x02013;macrophage colony-stimulating factor
(GM-CSF) levels than TB-negative individuals (the definition of TB-negativity
required AFB smear, culture and PCR negativity; <italic>P</italic> =
0&#x000b7;007), while all other cytokines/chemokines were not changed
statistically (<xref rid="tbl1" ref-type="table">Table 1</xref>). Upon comparing
the immune profile within the TB group, individuals with non-cavitary TB had
significantly higher BAL IL-7 and IP-10 than those with cavitary disease
(<italic>P</italic> = 0&#x000b7;02). Other cytokines/chemokines
were not associated significantly with radiographic findings or CD4 count.
Finally, immunohistochemistry of BAL cell blocks revealed that IP-10 was
produced by epithelial cells, monocytes/macrophages and neutrophils but
not lymphocytes (IHC positivity score 1&#x000b7;5 &#x000b1; 0&#x000b7;5, 1&#x000b7;6
&#x000b1; 0&#x000b7;5, 1&#x000b7;2 &#x000b1; 0&#x000b7;8 and 0&#x000b7;1 &#x000b1;
0&#x000b7;4, respectively; <italic>n</italic> = 12, <italic>P</italic>
= n.s. between epithelial cells, monocytes/macrophages and
neutrophils). Meanwhile, IL-7 was produced predominantly by epithelial cells and
monocytes/macrophages (IHC score 1&#x000b7;5 &#x000b1; 0&#x000b7;7 and
1&#x000b7;3 &#x000b1; 0&#x000b7;6 <italic>versus</italic> 0&#x000b7;7 &#x000b1;
0&#x000b7;6 and 0&#x000b7;0 &#x000b1; 0&#x000b7;0 for neutrophils and lymphocytes;
<italic>n</italic> = 11, <italic>P</italic> &#x0003c; 0&#x000b7;05
comparing epithelial cells and monocytes/macrophages
<italic>versus</italic> neutrophils or lymphocytes). For both IP-10 and
IL-7, the absence of lymphocyte staining may reflect their paucity, given HIV
infection.</p><fig position="float" id="fig02"><label>Fig. 2</label><caption><p>Inducible protein (IP)-10 and interleukin (IL)-7 in AIDS-associated
tuberculosis. Formalin-fixed, paraffin-embedded cell blocks were
prepared from bronchoalveolar lavage (BAL) fluid and
immunohistochemistry performed with anti-IP-10 and anti-IL-7 primary
antibody. Positive staining macrophages (arrows) and neutrophils
(arrowheads) are shown. No background staining was observed without
IP-10 (lower left) or IL-7 antibody (not shown). Ziehl&#x02013;Neelsen
(ZN) stain shows <italic>Mycobacterium tuberculosis</italic> bacilli
both inside neutrophils (arrowhead) and extracellularly (arrow). All
photomicrographs come from one of the seven patients with non-cavitary
tuberculosis.</p></caption><graphic xlink:href="cei0148-0254-f2" position="float"/></fig><table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Comparison of bronchoalveolar lavage (BAL) cytokine/chemokines
between HIV-infected patients with cavitary tuberculosis (TB),
non-cavitary TB and without tuberculosis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Cytokine/chemokine</th><th align="center" rowspan="1" colspan="1">TB cavitary (<italic>n</italic> = 6)</th><th align="center" rowspan="1" colspan="1">TB non-cavitary (<italic>n</italic> =
7)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> (cavitary
<italic>versus</italic> non-cavitary)</th><th align="center" rowspan="1" colspan="1">Non-TB (<italic>n</italic> = 21)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> (TB <italic>versus</italic>
non-TB)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IL-1&#x003b1;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">205&#x000b7;3 &#x000b1;
69&#x000b7;6</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">112&#x000b7;9 &#x000b1;
43&#x000b7;4</td><td align="center" rowspan="1" colspan="1">n.s.<xref rid="tf1-1" ref-type="table-fn">a</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">143&#x000b7;3 &#x000b1;
33&#x000b7;1</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-1&#x003b2;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">91&#x000b7;8 &#x000b1;
46&#x000b7;5</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">116&#x000b7;1 &#x000b1;
52&#x000b7;7</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">93&#x000b7;0 &#x000b1;
24&#x000b7;6</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-2</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">6&#x000b7;3 &#x000b1; 1&#x000b7;5</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4&#x000b7;6 &#x000b1; 1&#x000b7;4</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5&#x000b7;7 &#x000b1; 0&#x000b7;9</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-3</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1&#x000b7;1 &#x000b1; 1&#x000b7;1</td><td align="center" rowspan="1" colspan="1">n.d.<xref rid="tf1-2" ref-type="table-fn">b</xref></td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1&#x000b7;9 &#x000b1; 1&#x000b7;2</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-4</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">3&#x000b7;7 &#x000b1; 1&#x000b7;2</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2&#x000b7;9 &#x000b1; 1&#x000b7;2</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2&#x000b7;6 &#x000b1; 0&#x000b7;6</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-5</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">10&#x000b7;3 &#x000b1;
2&#x000b7;3</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">10&#x000b7;7 &#x000b1;
1&#x000b7;7</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">8&#x000b7;8 &#x000b1; 1&#x000b7;0</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-6</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">73&#x000b7;0 &#x000b1;
23&#x000b7;0</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">306&#x000b7;9 &#x000b1;
94&#x000b7;3</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">136&#x000b7;7 &#x000b1;
43&#x000b7;0</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-7</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">28&#x000b7;0 &#x000b1;
5&#x000b7;9</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">57&#x000b7;5 &#x000b1;
7&#x000b7;3</td><td align="center" rowspan="1" colspan="1">0&#x000b7;02</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">32&#x000b7;0 &#x000b1;
3&#x000b7;7</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-8</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">456&#x000b7;5 &#x000b1;
107&#x000b7;3</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1272&#x000b7;2 &#x000b1;
493&#x000b7;7</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">730&#x000b7;4 &#x000b1;
137&#x000b7;6</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-10</td><td align="center" rowspan="1" colspan="1">n.d.<xref rid="tf1-2" ref-type="table-fn">b</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5&#x000b7;5 &#x000b1; 4&#x000b7;5</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1&#x000b7;1 &#x000b1; 0&#x000b7;6</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-12p40</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">47&#x000b7;3 &#x000b1;
18&#x000b7;9</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">61&#x000b7;2 &#x000b1;
14&#x000b7;3</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">47&#x000b7;3 &#x000b1;
14&#x000b7;1</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-12p70</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">8&#x000b7;0 &#x000b1; 1&#x000b7;8</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">12&#x000b7;9 &#x000b1;
2&#x000b7;8</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">10&#x000b7;3 &#x000b1;
1&#x000b7;3</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-13</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">8&#x000b7;1 &#x000b1; 1&#x000b7;6</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">10&#x000b7;2 &#x000b1;
1&#x000b7;8</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">8&#x000b7;7 &#x000b1; 1&#x000b7;1</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-15</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4&#x000b7;8 &#x000b1; 2&#x000b7;2</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">7&#x000b7;9 &#x000b1; 3&#x000b7;8</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">7&#x000b7;5 &#x000b1; 1&#x000b7;4</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">IFN-&#x003b3;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">354&#x000b7;7 &#x000b1;
203&#x000b7;5</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">59&#x000b7;9 &#x000b1;
16&#x000b7;2</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">63&#x000b7;8 &#x000b1;
12&#x000b7;8</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">TGF-&#x003b2;1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2&#x000b7;2 &#x000b1; 1&#x000b7;1<xref rid="tf1-3" ref-type="table-fn">c</xref></td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2&#x000b7;8 &#x000b1; 1&#x000b7;5</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1&#x000b7;7 &#x000b1; 0&#x000b7;5<xref rid="tf1-3" ref-type="table-fn">c</xref></td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">25&#x000b7;6 &#x000b1;
20&#x000b7;9</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">10&#x000b7;3 &#x000b1;
5&#x000b7;9</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">10&#x000b7;3 &#x000b1;
3&#x000b7;5</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">Eotaxin</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">54&#x000b7;6 &#x000b1;
17&#x000b7;8</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">102&#x000b7;1 &#x000b1;
27&#x000b7;0</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">82&#x000b7;0 &#x000b1;
11&#x000b7;9</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">GM-CSF</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">8&#x000b7;1 &#x000b1; 1&#x000b7;6</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">12&#x000b7;9 &#x000b1;
2&#x000b7;2</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5&#x000b7;1 &#x000b1; 1&#x000b7;0</td><td align="center" rowspan="1" colspan="1">0&#x000b7;007</td></tr><tr><td align="left" rowspan="1" colspan="1">IP-10</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">350&#x000b7;5 &#x000b1;
203&#x000b7;5</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1709&#x000b7;9 &#x000b1;
604&#x000b7;4</td><td align="center" rowspan="1" colspan="1">0&#x000b7;02</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">306&#x000b7;2 &#x000b1;
75&#x000b7;1</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">MCP-1</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">42&#x000b7;6 &#x000b1;
13&#x000b7;3</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">117&#x000b7;6 &#x000b1;
39&#x000b7;7</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">47&#x000b7;3 &#x000b1;
6&#x000b7;2</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">MIP-1&#x003b1;</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">56&#x000b7;8 &#x000b1;
12&#x000b7;8</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">57&#x000b7;9 &#x000b1;
17&#x000b7;5</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">46&#x000b7;7 &#x000b1;
5&#x000b7;0</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" rowspan="1" colspan="1">RANTES</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">37&#x000b7;0 &#x000b1;
4&#x000b7;7</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">64&#x000b7;2 &#x000b1;
14&#x000b7;8</td><td align="center" rowspan="1" colspan="1">n.s.</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">318 &#x000b1; 3&#x000b7;2</td><td align="center" rowspan="1" colspan="1">n.s.</td></tr></tbody></table><table-wrap-foot><fn><p>Data shown as mean &#x000b1; s.e. pg cytokine/mg protein.</p></fn><fn id="tf1-1"><label>a</label><p>n.s. = Not statistically significant.
<italic>P</italic>-values reflect <italic>t</italic>-test; however,
all significant <italic>P</italic>-values were also met when
comparing medians (Mann&#x02013;Whitney test).</p></fn><fn id="tf1-2"><label>b</label><p>n.d. = Not detected for any specimen.</p></fn><fn id="tf1-3"><label>c</label><p>Transforming growth factor (TGF)-&#x003b2;1 data available for only
six cavitary TB specimens and 19 non-TB specimens. GM-CSF:
granulocyte&#x02013;macrophage colony-stimulating factor; RANTES:
regulated upon activation normal T cell expressed and secreted
cytokines; IL: interleukin; IFN: interferon; TNF: tumour necrosis
factor; IP: inducible protein; MCP: monocyte chemoattractant
protein; MIP: macrophage inflammatory protein.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><p>The importance of this work lies in the characterization of the immune profile at the
site of infection from a substantial number of HIV-infected, probe-confirmed TB
patients from sub-Saharan Africa. Many studies from developing world sites perform
only smear or culture but not probe or PCR for confirmation of <italic>M.
tuberculosis</italic> complex. This would have led to a significant rate of
erroneous assignment to both the TB-positive and TB-negative groups in our
population. As a noteworthy aside, we feel that PCR directly on BAL, while
technically demanding in a resource-limited setting, has tremendous advantages in
terms of accuracy over smear and rapidity over culture/probe.</p><p>The comparison of cytokine responses between the TB and non-TB groups revealed a
statistical increase in BAL GM-CSF in the setting of TB, a finding that has not been
reported previously. One might predict that this chemokine may exert a partially
protective response, given its role in TB containment and granuloma development in
mice [<xref rid="b16" ref-type="bibr">16</xref>]. Whether additional
exogenous GM-CSF would be therapeutic in active TB is unknown: in one small study
clinical improvement was modest [<xref rid="b17" ref-type="bibr">17</xref>]. Potentially driven by the increase in GM-CSF, the BAL
neutrophilic response we saw in these TB patients was notable, particularly given
the abundant bacilli within the neutrophils. The role of neutrophils in TB is
unresolved: intracellular killing has been demonstrated <italic>in vitro</italic> by
some but not others [<xref rid="b18" ref-type="bibr">18</xref>,<xref rid="b19" ref-type="bibr">19</xref>]. In mouse models, neutrophils do not
affect survival but do contribute to granuloma formation [<xref rid="b20" ref-type="bibr">20</xref>,<xref rid="b21" ref-type="bibr">21</xref>]. Taken together, we speculate that the increased GM-CSF and
neutrophil response is an attempt by the host to control TB, particularly in the
setting of AIDS.</p><p>The association we found between CD4 count and cavitary disease and endobronchial TB
burden was not surprising. Several studies have documented this trend [<xref rid="b5" ref-type="bibr">5</xref>&#x02013;<xref rid="b8" ref-type="bibr">8</xref>,<xref rid="b10" ref-type="bibr">10</xref>], supporting the
hypothesis that CD4 cells contribute to the pathogenesis of cavitary disease and
endobronchial spread. The mechanism by which this cavitation process occurs is
clearly of paramount importance to the AIDS/TB epidemic due to its
implication on TB transmission. We therefore sought to examine the
cytokine/chemokine profile between the cavitary and non-cavitary groups.
Based on limited human or mouse data we predicted a correlation between loss of
cavitation and a loss of tumour necrosis factor (TNF)-&#x003b1; or interferon
(IFN)-&#x003b3; [<xref rid="b22" ref-type="bibr">22</xref>&#x02013;<xref rid="b24" ref-type="bibr">24</xref>]; however, diminution of these
cytokines in the non-cavitary group was modest and not statistically significant.
More readily apparent was the association between the loss of cavitation and IL-7
and IP-10. To our knowledge, IL-7 has not been reported in the BAL of TB patients.
One could postulate that the IL-7 is merely a marker for the advanced AIDS of the
non-cavitary group, given its association with CD4 decline [<xref rid="b25" ref-type="bibr">25</xref>]; however, IL-7 may be relevant to
HIV pathogenesis via its up-regulation of regulated upon activation normal T cell
expressed and secreted cytokines (RANTES) (and thereby promotion X4 virus)
[<xref rid="b26" ref-type="bibr">26</xref>]. The localization of
IL-7 production by immunohistochemistry to bronchial epithelial cells and
macrophages was not surprising, and has been reported by others [<xref rid="b27" ref-type="bibr">27</xref>,<xref rid="b28" ref-type="bibr">28</xref>].</p><p>IP-10 is an IFN-&#x003b3;-inducible chemokine critical for effector T cell development
and trafficking in mice [<xref rid="b29" ref-type="bibr">29</xref>].
Its elevation during TB has been reported [<xref rid="b20" ref-type="bibr">20</xref>,<xref rid="b30" ref-type="bibr">30</xref>]; however, a
neutrophilic source has not been described. Some authors postulate a protective role
for this chemokine [<xref rid="b31" ref-type="bibr">31</xref>], yet
our findings of extremely high levels in the advanced AIDS/non-cavitary group
would argue against an unequivocally protective function for IP-10. Indeed, given
the positive effect of IFN-&#x003b3; on IP-10 transcription (as well as that of
IL-1&#x003b1; and TNF-&#x003b1; in some systems [<xref rid="b32" ref-type="bibr">32</xref>]), the high IP-10/low IFN-&#x003b3;/low
IL-1&#x003b1;/low TNF-&#x003b1; pattern of the non-cavitary group was
unexpected and suggest loss of IP-10 regulation or induction by other known
mediators such as Toll-like receptor ligands [<xref rid="b33" ref-type="bibr">33</xref>,<xref rid="b34" ref-type="bibr">34</xref>].</p><p>Human data are important to direct research in experimental and animal models,
particularly given the complexity of AIDS-associated TB which cannot be replicated
easily. Based upon our findings we question the role of GM-CSF and neutrophils
during AIDS-associated TB. Additionally, the function of IL-7 on TB-specific HIV
progression and of IP-10 in T cell trafficking in TB would seem to be fertile topics
for research.</p></sec></body><back><ack><p>This work was supported by a grant from the University of Virginia Research and
Development Committee (E. R. H.) and the University of Virginia Center for Global
Health Pfizer initiative (G. S. K.). We thank the UVA Clinical Mycobacteriology
Laboratory for their assistance with culture, the UVA Flow Cytometry Center for
assistance with cytokine detection and the UVA Digestive Health Center of Excellence
Histology Core (supported by NIH P30DK56703) for immunohistochemistry support. We
also thank Stephen Gillespie and W. Michael Scheld for advice.</p></ack><ref-list><title>References</title><ref id="b1"><label>1</label><element-citation publication-type="other"><collab>World Health Organization (WHO)</collab><article-title>Global Tuberculosis Control</article-title><comment>WHO/HTM/TB/2006.362. Geneva: WHO, 2006.</comment></element-citation></ref><ref id="b2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whalen</surname><given-names>CC</given-names></name><name><surname>Nsubuga</surname><given-names>P</given-names></name><name><surname>Okwera</surname><given-names>A</given-names></name><etal/></person-group><article-title>Impact of pulmonary tuberculosis on survival of HIV-infected
adults: a prospective epidemiologic study in Uganda</article-title><source>AIDS</source><year>2000</year><volume>14</volume><fpage>1219</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">10894287</pub-id></element-citation></ref><ref id="b3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>KR</given-names></name><name><surname>Mayanja-Kizza</surname><given-names>H</given-names></name><name><surname>Sullivan</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Greater diversity of HIV-1 quasispecies in HIV-infected
individuals with active tuberculosis</article-title><source>J Acquir Immune Defic Syndr</source><year>2000</year><volume>24</volume><fpage>408</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">11035611</pub-id></element-citation></ref><ref id="b4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goletti</surname><given-names>D</given-names></name><name><surname>Weissman</surname><given-names>D</given-names></name><name><surname>Jackson</surname><given-names>RW</given-names></name><etal/></person-group><article-title>Effect of <italic>Mycobacterium tuberculosis</italic> on HIV
replication. Role of immune activation</article-title><source>J Immunol</source><year>1996</year><volume>157</volume><fpage>1271</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8757635</pub-id></element-citation></ref><ref id="b5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitchenik</surname><given-names>AE</given-names></name><name><surname>Rubinson</surname><given-names>HA</given-names></name></person-group><article-title>The radiographic appearance of tuberculosis in patients with the
acquired immune deficiency syndrome (AIDS) and pre-AIDS</article-title><source>Am Rev Respir Dis</source><year>1985</year><volume>131</volume><fpage>393</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3977176</pub-id></element-citation></ref><ref id="b6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lado Lado</surname><given-names>FL</given-names></name><name><surname>Barrio Gomez</surname><given-names>E</given-names></name><name><surname>Carballo Arceo</surname><given-names>E</given-names></name><etal/></person-group><article-title>Clinical presentation of tuberculosis and the degree of
immunodeficiency in patients with HIV infection</article-title><source>Scand J Infect Dis</source><year>1999</year><volume>31</volume><fpage>387</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">10528879</pub-id></element-citation></ref><ref id="b7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlman</surname><given-names>DC</given-names></name><name><surname>el-Sadr</surname><given-names>WM</given-names></name><name><surname>Nelson</surname><given-names>ET</given-names></name><etal/></person-group><article-title>Variation of chest radiographic patterns in pulmonary
tuberculosis by degree of human immunodeficiency virus-related
immunosuppression</article-title><source>Clin Infect Dis</source><year>1997</year><volume>25</volume><fpage>242</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9332519</pub-id></element-citation></ref><ref id="b8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keiper</surname><given-names>MD</given-names></name><name><surname>Beumont</surname><given-names>M</given-names></name><name><surname>Elshami</surname><given-names>A</given-names></name><etal/></person-group><article-title>CD4 T lymphocyte count and the radiographic presentation of
pulmonary tuberculosis. A study of the relationship between these factors in
patients with human immunodeficiency virus infection</article-title><source>Chest</source><year>1995</year><volume>107</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">7813316</pub-id></element-citation></ref><ref id="b9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nambuya</surname><given-names>A</given-names></name><name><surname>Sewankambo</surname><given-names>N</given-names></name><name><surname>Mugerwa</surname><given-names>J</given-names></name><etal/></person-group><article-title>Tuberculouslymphadenitis associated with human immunodeficiency
virus (HIV) in Uganda</article-title><source>J Clin Pathol</source><year>1988</year><volume>41</volume><fpage>93</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3343383</pub-id></element-citation></ref><ref id="b10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosset</surname><given-names>J</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> in the extracellular
compartment: an underestimated adversary</article-title><source>Antimicrob Agents Chemother</source><year>2003</year><volume>47</volume><fpage>833</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12604509</pub-id></element-citation></ref><ref id="b11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pounder</surname><given-names>JI</given-names></name><name><surname>Aldous</surname><given-names>WK</given-names></name><name><surname>Woods</surname><given-names>GL</given-names></name></person-group><article-title>Comparison of real-time polymerase chain reaction using the Smart
Cycler and the General-Probe amplified <italic>Mycobacterium
tuberculosis</italic> direct test for detection of <italic>M.
tuberculosis</italic> complex in clinical specimens</article-title><source>Diagn Microbiol Infect Dis</source><year>2006</year><volume>54</volume><fpage>217</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">16423496</pub-id></element-citation></ref><ref id="b12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Valliere</surname><given-names>S</given-names></name><name><surname>Barker</surname><given-names>RD</given-names></name></person-group><article-title>Residual lung damage after completion of treatment for
multidrug-resistant tuberculosis</article-title><source>Int J Tuberc Lung Dis</source><year>2004</year><volume>8</volume><fpage>767</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15182148</pub-id></element-citation></ref><ref id="b13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsao</surname><given-names>TC</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Chiou</surname><given-names>WK</given-names></name><etal/></person-group><article-title>Levels of interferon-gamma and interleukin-2 receptor-alpha for
bronchoalveolar lavage fluid and serum were correlated with clinical grade
and treatment of pulmonary tuberculosis</article-title><source>Int J Tuberc Lung Dis</source><year>2002</year><volume>6</volume><fpage>720</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12150485</pub-id></element-citation></ref><ref id="b14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ameglio</surname><given-names>F</given-names></name><name><surname>Casarini</surname><given-names>M</given-names></name><name><surname>Capoluongo</surname><given-names>E</given-names></name><etal/></person-group><article-title>Post-treatment changes of six cytokines in active pulmonary
tuberculosis: differences between patients with stable or increased
fibrosis</article-title><source>Int J Tuberc Lung Dis</source><year>2005</year><volume>9</volume><fpage>98</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">15675558</pub-id></element-citation></ref><ref id="b15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morosini</surname><given-names>M</given-names></name><name><surname>Meloni</surname><given-names>F</given-names></name><name><surname>Uccelli</surname><given-names>M</given-names></name><etal/></person-group><article-title><italic>Ex vivo</italic> evaluation of PPD-specific IFN-gamma or
IL-5 secreting cells in the peripheral blood and lungs of patients with
tuberculosis</article-title><source>Int J Tuberc Lung Dis</source><year>2005</year><volume>9</volume><fpage>753</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16013770</pub-id></element-citation></ref><ref id="b16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Juarrero</surname><given-names>M</given-names></name><name><surname>Hattle</surname><given-names>JM</given-names></name><name><surname>Izzo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Disruption of granulocyte macrophage-colony stimulating factor
production in the lungs severely affects the ability of mice to control
<italic>Mycobacterium tuberculosis</italic> infection</article-title><source>J Leukoc Biol</source><year>2005</year><volume>77</volume><fpage>914</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15767289</pub-id></element-citation></ref><ref id="b17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedral-Sampaio</surname><given-names>DB</given-names></name><name><surname>Netto</surname><given-names>EM</given-names></name><name><surname>Brites</surname><given-names>C</given-names></name><etal/></person-group><article-title>Use of Rhu-GM-CSF in pulmonary tuberculosis patients: results of
a randomized clinical trial</article-title><source>Braz J Infect Dis</source><year>2003</year><volume>7</volume><fpage>245</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">14533985</pub-id></element-citation></ref><ref id="b18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>GS</given-names></name><name><surname>Amirault</surname><given-names>HJ</given-names></name><name><surname>Andersen</surname><given-names>BR</given-names></name></person-group><article-title>Killing of <italic>Mycobacterium tuberculosis</italic> by
neutrophils: a nonoxidative process</article-title><source>J Infect Dis</source><year>1990</year><volume>162</volume><fpage>700</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">2167338</pub-id></element-citation></ref><ref id="b19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>M</given-names></name></person-group><article-title>Human neutrophils, activated with cytokines or not, do not kill
virulent <italic>Mycobacterium tuberculosis</italic></article-title><source>J Infect Dis</source><year>1991</year><volume>163</volume><fpage>919</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">1901338</pub-id></element-citation></ref><ref id="b20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seiler</surname><given-names>P</given-names></name><name><surname>Aichele</surname><given-names>P</given-names></name><name><surname>Bandermann</surname><given-names>S</given-names></name><etal/></person-group><article-title>Early granuloma formation after aerosol <italic>Mycobacterium
tuberculosis</italic> infection is regulated by neutrophils via
CXCR3-signaling chemokines</article-title><source>Eur J Immunol</source><year>2003</year><volume>33</volume><fpage>2676</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">14515251</pub-id></element-citation></ref><ref id="b21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seiler</surname><given-names>P</given-names></name><name><surname>Aichele</surname><given-names>P</given-names></name><name><surname>Raupach</surname><given-names>B</given-names></name><etal/></person-group><article-title>Rapid neutrophil response controls fast-replicating intracellular
bacteria but not slow-replicating <italic>Mycobacterium
tuberculosis</italic></article-title><source>J Infect Dis</source><year>2000</year><volume>181</volume><fpage>671</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">10669354</pub-id></element-citation></ref><ref id="b22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keane</surname><given-names>J</given-names></name><name><surname>Gershon</surname><given-names>S</given-names></name><name><surname>Wise</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Tuberculosis associated with infliximab, a tumor necrosis factor
alpha-neutralizing agent</article-title><source>N Engl J Med</source><year>2001</year><volume>345</volume><fpage>1098</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">11596589</pub-id></element-citation></ref><ref id="b23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsao</surname><given-names>TC</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>LF</given-names></name><etal/></person-group><article-title>Imbalances between tumor necrosis factor-alpha and its soluble
receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist
in BAL fluid of cavitary pulmonary tuberculosis</article-title><source>Chest</source><year>2000</year><volume>117</volume><fpage>103</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10631206</pub-id></element-citation></ref><ref id="b24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>AM</given-names></name><name><surname>Dalton</surname><given-names>DK</given-names></name><name><surname>Stewart</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Disseminated tuberculosis in interferon gamma gene-disrupted
mice</article-title><source>J Exp Med</source><year>1993</year><volume>178</volume><fpage>2243</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8245795</pub-id></element-citation></ref><ref id="b25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napolitano</surname><given-names>LA</given-names></name><name><surname>Grant</surname><given-names>RM</given-names></name><name><surname>Deeks</surname><given-names>SG</given-names></name><etal/></person-group><article-title>Increased production of IL-7 accompanies HIV-1-mediated T-cell
depletion: implications for T-cell homeostasis</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><fpage>73</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11135619</pub-id></element-citation></ref><ref id="b26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llano</surname><given-names>A</given-names></name><name><surname>Barretina</surname><given-names>J</given-names></name><name><surname>Gutierrez</surname><given-names>A</given-names></name><etal/></person-group><article-title>Interleukin-7-dependent production of RANTES that correlates with
human immunodeficiency virus disease progression</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>4389</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">12634395</pub-id></element-citation></ref><ref id="b27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caufour</surname><given-names>P</given-names></name><name><surname>Le Grand</surname><given-names>R</given-names></name><name><surname>Cheret</surname><given-names>A</given-names></name><etal/></person-group><article-title>Longitudinal analysis of CD8(+) T-cell phenotype and IL-7,
IL-15 and IL-16 mRNA expression in different tissues during primary simian
immunodeficiency virus infection</article-title><source>Microbes Infect</source><year>2001</year><volume>3</volume><fpage>181</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">11358712</pub-id></element-citation></ref><ref id="b28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>E</given-names></name><name><surname>Kohrogi</surname><given-names>H</given-names></name><name><surname>Hirata</surname><given-names>N</given-names></name><etal/></person-group><article-title>Human bronchial intraepithelial T lymphocytes as a distinct
T-cell subset: their long-term survival in SCID-Hu chimeras</article-title><source>Am J Respir Cell Mol Biol</source><year>2000</year><volume>22</volume><fpage>405</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">10745021</pub-id></element-citation></ref><ref id="b29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dufour</surname><given-names>JH</given-names></name><name><surname>Dziejman</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>MT</given-names></name><etal/></person-group><article-title>IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice
reveal a role for IP-10 in effector T cell generation and
trafficking</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>3195</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">11907072</pub-id></element-citation></ref><ref id="b30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauty</surname><given-names>A</given-names></name><name><surname>Dziejman</surname><given-names>M</given-names></name><name><surname>Taha</surname><given-names>RA</given-names></name><etal/></person-group><article-title>The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are
expressed by activated human bronchial epithelial cells</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>3549</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">10092813</pub-id></element-citation></ref><ref id="b31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raju</surname><given-names>B</given-names></name><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Kuwabara</surname><given-names>K</given-names></name><etal/></person-group><article-title>Aerosolized gamma interferon (IFN-gamma) induces expression of
the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not
inducible nitric oxide synthase in the lung during
tuberculosis</article-title><source>Infect Immun</source><year>2004</year><volume>72</volume><fpage>1275</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">14977928</pub-id></element-citation></ref><ref id="b32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnis</surname><given-names>KA</given-names></name><name><surname>Britain</surname><given-names>A</given-names></name><name><surname>Lausch</surname><given-names>RN</given-names></name><etal/></person-group><article-title>Synthesis of alpha-chemokines IP-10, I-TAC, and MIG are
differentially regulated in human corneal keratocytes</article-title><source>Invest Ophthalmol Vis Sci</source><year>2005</year><volume>46</volume><fpage>1668</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">15851567</pub-id></element-citation></ref><ref id="b33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vollmer</surname><given-names>J</given-names></name><name><surname>Jurk</surname><given-names>M</given-names></name><name><surname>Samulowitz</surname><given-names>U</given-names></name><etal/></person-group><article-title>CpG oligodeoxynucleotides stimulate IFN-gamma-inducible
protein-10 production in human B cells</article-title><source>J Endotoxin Res</source><year>2004</year><volume>10</volume><fpage>431</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15588427</pub-id></element-citation></ref><ref id="b34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopydlowski</surname><given-names>KM</given-names></name><name><surname>Salkowski</surname><given-names>CA</given-names></name><name><surname>Cody</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Regulation of macrophage chemokine expression by
lipopolysaccharide <italic>in vitro</italic> and <italic>in
vivo</italic></article-title><source>J Immunol</source><year>1999</year><volume>163</volume><fpage>1537</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">10415057</pub-id></element-citation></ref></ref-list></back></article>
